Medical technology
The goal is to support innovation that meets the needs of the UK population, such as by addressing clinical priorities and increasing sustainability.
Right price The Government plans to create an environment that supports the understanding and delivery of value for money and affordability across the whole patient pathway, using high quality data to ensure that prices are reasonable for the health system and sustainable for suppliers. The report further states that to ensure the best value for public money, the value of MedTech products “should not be considered in isolation, but across the whole patient pathway.” Affordability, long term value, and patient outcomes must form part of this assessment, as well as an acknowledgement that “lowest price does not always translate to best value”. Clear, reliable data to underpin decisions will
be required to achieve this. It emphasises that the importance of getting the right products at the right price will be even more important in the face of increasing pressures due to changing demographics and inflation.
Right place The Government also pledges to ensure the UK
is positioned internationally and domestically to increase access, diversity, and resilience in the supply market, to get technology to the patients and healthcare professionals who need them. It states that confidence in the availability of
MedTech products at the time they are needed is critical to the functioning of the health and care system. It says that access to the right products, delivery of them via a responsive and resilient supply chain and supporting their adoption into the UK health and care system will ensure everyone has access to medical technology – as and when they need it.
Key priorities As part of the strategy, the Government has identified four key priority areas: Priority one: resilience and continuity of
supply. The blueprint for MedTech points out that increasing consolidation in the sector and globalisation of production and supply chains has reduced resilience. Recent events, including the COVID-19 pandemic and the war in Ukraine, and the subsequent disruption of global trading and logistics systems has brought to light vulnerabilities within many MedTech supply chains where an over-reliance on single locations or sources of materials and supporting services exists.
The report states that there is currently a
“high reliance on stockpiles” to ensure continuity of supply and adds that “multiple organisations have a responsibility to ensure supply is robust.” Therefore, there is a clear need to set the direction of travel for the mid-and long-term in a way that “proactively addresses resilience” and “pre-emptively plans for and mitigates risks to supply”. Priority two: innovative and dynamic markets.
Innovative MedTech offers an important opportunity to improve patient outcomes and help deliver best value for taxpayer money. Despite this, it is not always clear what the health and social care system wants and needs, and this can be further complicated by high levels of unwarranted variation in product use across the NHS, and barriers to switching between products. There are many initiatives and pathways designed to address specific challenges – in particular, new and transformative product innovations. The area would benefit from additional coherence and co-ordination for new and existing products in the system to help ensure the best products get to patients, faster. Priority three: enabling infrastructure.
The MedTech sector will need an underlying framework of enablers. A lack of enablers in the
Reinforced Sterile Barrier System for the packaging of heavy and bulky devices and surgery trays
Resistance to tearing gives it much higher integrity.
Tested to maintain sterility for up to 12 months(single packaging) in hospital conditions.
Compared to standard envelope-type packaging
(wraps), ULTRA considerably reduces the volume of
packaging materials used.
The trasparent film side
allows users to view/ check content of surgical trays before opening without compromising sterility.
Reduce packaging by using
Standard Trays Heavy Surgical Trays (Orthopedics) Loan Sets Complex Devices (robot, fragile,edged)
in your CSSD March 2023 I
www.clinicalservicesjournal.com 27
▲
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64
